[HTML][HTML] Whole exome sequencing identifies genetic variants in inherited thrombocytopenia with secondary qualitative function defects

…, P Collins, N Curry, C Grimley, B James… - …, 2016 - ncbi.nlm.nih.gov
Inherited thrombocytopenias are a heterogeneous group of disorders characterized by
abnormally low platelet counts which can be associated with abnormal bleeding. Next-generation …

Critical review of current clinical practice guidelines for antifungal therapy in paediatric haematology and oncology

…, H Hassan, JV Cockle, C Lethaby, B James… - Supportive Care in …, 2017 - Springer
Purpose The incidence of invasive fungal disease (IFD) is rising, but its treatment in paediatric
haematology and oncology patients is not yet standardised. This review aimed to critically …

Guidelines for the investigation and management of Transient Leukaemia of Down Syndrome

O Tunstall, N Bhatnagar, B James, A Norton… - British Journal of …, 2018 - ora.ox.ac.uk
Methodology This guideline was compiled according to the British Society for Haematology (BSH)
process at (http://www.bcshguidelines.com). The Grading of Recommendations …

T-cell replete cord transplants give superior outcomes in high-risk and relapsed/refractory pediatric myeloid malignancy

…, J Jovanovic, R Dillon, P Virgo, B James… - Blood …, 2023 - ashpublications.org
Stem cell transplant (SCT) outcomes in high-risk and relapsed/refractory (R/R) pediatric acute
myeloid leukemia (AML) and myelodysplastic syndrome (MDS) have been historically poor…

Blinatumomab for infant acute lymphoblastic leukemia

…, K Patrick, D Bonney, B James… - Blood, The Journal …, 2020 - ashpublications.org
Unlike older children with acute lymphoblastic leukemia (ALL), there has been almost no
improvement in outcome for infants in the last 2 decades. Six-year event-free survival (EFS) …

Adjuvant tyrosine kinase inhibitor therapy improves outcome for children and adolescents with acute lymphoblastic leukaemia who have an ABL‐class fusion

…, N Goulden, P Kearns, B James… - British journal of …, 2020 - Wiley Online Library
Patients with an ABL‐class fusion have a high risk of relapse on standard chemotherapy but
are sensitive to tyrosine kinase inhibitors (TKI). In UKALL2011, we screened patients with …

Use of eculizumab in children with allogeneic haematopoietic stem cell transplantation associated thrombotic microangiopathy-a multicentre retrospective PDWP and …

…, G Krivan, C Speckmann, B James… - Bone Marrow …, 2023 - nature.com
Terminal complement blockade by humanised monoclonal antibody eculizumab has been
used to treat transplantation-associated thrombotic microangiopathy (TA-TMA) in recent years…

[HTML][HTML] COVID‐19 infection in paediatric recipients of allogeneic stem cell transplantation: the UK experience

…, R Wynn, M Slatter, B Shillitoe, B James… - British Journal of …, 2021 - ncbi.nlm.nih.gov
In January 2020, a novel coronavirus was sequenced in China (SARS-CoV-2) and it was
linked to cases of severe acute respiratory syndrome as part of a new disease which was …

Excellent overall and chronic graft‐versus‐host‐disease‐free event‐free survival in Fanconi anaemia patients undergoing matched related‐ and unrelated‐donor …

…, M Cummins, K Patrick, B James… - British Journal of …, 2021 - Wiley Online Library
Haematopoietic stem cell transplantation (HSCT) remains the only curative option in Fanconi
anaemia (FA). We analysed the outcome of children transplanted for FA between 1999 and …

Diagnostic evaluation of paediatric autoimmune lymphoproliferative immunodeficiencies (ALPID): a prospective cohort study

…, S Heine, E Huisman, G Jakovljevic, B James… - The Lancet …, 2024 - thelancet.com
Background Lymphoproliferation and autoimmune cytopenias characterise autoimmune
lymphoproliferative syndrome. Other conditions sharing these manifestations have been termed …